PLAGL2 and prostate carcinoma: Emerging evidence has revealed that PLAGL2 acts as an oncogene in various cancers, such as neuroblastoma, non‐small cell lung cancer, prostate cancer, colorectal cancer, and leukemia.27, 28, 29, 30